1.
Seubwai W, Vaeteewoottacharn K, Umezawa K, Okada S, Wongkham S. Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters. SRIMEDJ [Internet]. 2013 Nov. 27 [cited 2024 Apr. 26];28(4):171. Available from: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/14789